Remote GxP Consultancy
We provide a wide range of virtual and remote pharmaceutical auditing, consulting and training services aimed to help companies to continue operating under the COVID-19 restrictions.
NSF International now offers the services of a full contract research organization (CRO), and has significant expertise conducting biomedical research. Our team’s combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. These services include:
We can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application.
We have developed and trialed a four-step approach that helps unlock supply chains and meet cGMP needs in technology transfer, clinical trial supply and routine operation. This approach allows for a risk-based method that will help to provide interim or conditional approval of facilities and quality systems -- especially during periods of uncertainty and governmental restrictions.
Our consulting services relevant during these difficult times include:
When in-person learning or training is not possible, we offer options to keep staff up to date.
eLearning: Our full range of eLearning courses for both the pharmaceutical and medical device industries can be customized to meet your organizational needs. Now is the perfect time to educate your entire workforce, groups or individual employees in topics relevant to their job role.
Virtual training: With many more of us working together remotely, we are now offering our training programs virtually with experts to guide you in an interactive and engaging virtual classroom. Our instructor-led training can be customized to your organizational requirements – we are already working with our clients to meet their exact needs.
Do not postpone the development of your staff; maximize their contribution to the business and improve your competitive edge. Our virtual training courses complement our 2020 public training schedule.
NSF International’s Health Sciences Team Joins Fight to Save Lives With More Ventilators
April 23, 2020
NSF International’s health sciences team is hands-on in the rapid ventilator manufacturing specification issued by the United Kingdom (UK) government. The UK National Health Service needs thousands more ventilators to help save lives as the country’s COVID-19 pandemic approaches its expected peak and ventilator capacity becomes a challenge.
Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA
April 2, 2020
How NSF International Is Addressing Coronavirus Disease 2019 (COVID-19)
April 1, 2020
These are uncertain and anxious times, so we want to assure you that NSF International is taking proactive steps to minimize the spread of COVID-19.
OEHHA Issues Proposed NSRLs for Three Disinfection By-Products
August 11, 2020
On May 22, the California Office of Environmental Health Hazard Assessment (OEHHA), which assesses health risks of environmental contaminants in products sold in California, issued three notices of proposed rulemaking (NPRs) establishing proposed no significant risk levels (NSRLs) for three water disinfection by-products : trichloroacetic acid, dibromoacetic acid and dichloroacetic acid; also known as haloacetic acids. These NPRs were open for comment until July 7. OEHHA is now reviewing the comments and will then issue a final rule.